PLK1 inhibitors (Yangtze River Pharmaceutical)
N/A
Report date: 2025/03/20 14:39:16
NME
Base Information
Drug NamePLK1 inhibitors (Yangtze River Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYangtze River Pharmaceutical (Group) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesYangtze River Pharmaceutical (Group) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A